2001
DOI: 10.1046/j.1468-0734.2001.00050.x
|View full text |Cite
|
Sign up to set email alerts
|

RAREACQUIREDBLEEDINGDISORDERS

Abstract: Accurate diagnosis of the cause of bleeding is a prerequisite for determination of the optimal therapeutic response. Clinicians are generally aware of the more prevalent hemorrhagic syndromes but some rare acquired conditions are also of importance. In many of these, inhibitors of coagulation factors or of platelet adhesion/aggregation cause bleeding. These inhibitors are generally, but not always, immunoglobulins. In this review, the less common inhibitors of coagulation and hemostasis, as well as some import… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 165 publications
0
3
0
Order By: Relevance
“…The two main lines of therapy are the haemostatic therapy for the haemorrhage and immunotherapy in order to eradicate the antibodies [8]. At most centres, the first-line therapy usually includes the recombinant factor VII or activated prothrombin complex concentrate is used until the bleeding is controlled [13]. Steroids alone or in combination with cyclophosphamide has also been a recommended first-line therapy.…”
Section: Discussionmentioning
confidence: 99%
“…The two main lines of therapy are the haemostatic therapy for the haemorrhage and immunotherapy in order to eradicate the antibodies [8]. At most centres, the first-line therapy usually includes the recombinant factor VII or activated prothrombin complex concentrate is used until the bleeding is controlled [13]. Steroids alone or in combination with cyclophosphamide has also been a recommended first-line therapy.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to the rare inherited deficiencies, coagulation factor deficiencies are acquired commonly. 16 These include deficiencies secondary to autoantibody formation leading to neutralization of factor activity or rarely, accelerated clearance from the circulation. 17 Other acquired causes include decreased production (eg, liver disease), impaired synthesis (eg, vitamin K deficiency), and increased destruction (disseminated intravascular coagulation and thrombolytic therapy).…”
Section: Acquired Factor Deficienciesmentioning
confidence: 99%
“…Acquired haemophilia is a rare but potentially life‐threatening condition. Acquired antibodies are most commonly directed against factor VIII but may also be directed against the other coagulation factors (Watson et al , 2001).…”
Section: Clinical Studiesmentioning
confidence: 99%